Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Analyzing the genes related to nicotine addiction or schizophrenia via a pathway and network based approach.

Hu Y, Fang Z, Yang Y, Rohlsen-Neal D, Cheng F, Wang J.

Sci Rep. 2018 Feb 13;8(1):2894. doi: 10.1038/s41598-018-21297-x.

2.

Genetic risk for schizophrenia and psychosis in Alzheimer disease.

DeMichele-Sweet MAA, Weamer EA, Klei L, Vrana DT, Hollingshead DJ, Seltman HJ, Sims R, Foroud T, Hernandez I, Moreno-Grau S, Tárraga L, Boada M, Ruiz A, Williams J, Mayeux R, Lopez OL, Sibille EL, Kamboh MI, Devlin B, Sweet RA.

Mol Psychiatry. 2018 Apr;23(4):963-972. doi: 10.1038/mp.2017.81. Epub 2017 May 2.

3.

BMS-933043, a Selective α7 nAChR Partial Agonist for the Treatment of Cognitive Deficits Associated with Schizophrenia.

King D, Iwuagwu C, Cook J, McDonald IM, Mate R, Zusi FC, Hill MD, Fang H, Zhao R, Wang B, Easton AE, Miller R, Post-Munson D, Knox RJ, Gallagher L, Westphal R, Molski T, Fan J, Clarke W, Benitex Y, Lentz KA, Denton R, Morgan D, Zaczek R, Lodge NJ, Bristow LJ, Macor JE, Olson RE.

ACS Med Chem Lett. 2017 Feb 8;8(3):366-371. doi: 10.1021/acsmedchemlett.7b00032. eCollection 2017 Mar 9.

4.

Genetic knockout of the α7 nicotinic acetylcholine receptor gene alters hippocampal long-term potentiation in a background strain-dependent manner.

Freund RK, Graw S, Choo KS, Stevens KE, Leonard S, Dell'Acqua ML.

Neurosci Lett. 2016 Aug 3;627:1-6. doi: 10.1016/j.neulet.2016.05.043. Epub 2016 May 24.

6.

Clinical and Genetic Heterogeneity of the 15q13.3 Microdeletion Syndrome.

Hassfurther A, Komini E, Fischer J, Leipoldt M.

Mol Syndromol. 2016 Feb;6(5):222-8. doi: 10.1159/000443343. Epub 2016 Jan 16.

7.

A Review of Impact of Tobacco Use on Patients with Co-occurring Psychiatric Disorders.

Pal A, Balhara YP.

Tob Use Insights. 2016 Mar 10;9:7-12. doi: 10.4137/TUI.S32201. eCollection 2016. Review.

8.

nAChR dysfunction as a common substrate for schizophrenia and comorbid nicotine addiction: Current trends and perspectives.

Parikh V, Kutlu MG, Gould TJ.

Schizophr Res. 2016 Mar;171(1-3):1-15. doi: 10.1016/j.schres.2016.01.020. Epub 2016 Jan 21. Review.

9.

Endophenotypes in Schizophrenia for the Perinatal Period: Criteria for Validation.

Ross RG, Freedman R.

Schizophr Bull. 2015 Jul;41(4):824-34. doi: 10.1093/schbul/sbv054. Epub 2015 May 4. Review.

10.

A Human-Specific α7-Nicotinic Acetylcholine Receptor Gene in Human Leukocytes: Identification, Regulation and the Consequences of CHRFAM7A Expression.

Costantini TW, Dang X, Yurchyshyna MV, Coimbra R, Eliceiri BP, Baird A.

Mol Med. 2015 Apr 3;21:323-36. doi: 10.2119/molmed.2015.00018.

11.

CHRFAM7A: a human-specific α7-nicotinic acetylcholine receptor gene shows differential responsiveness of human intestinal epithelial cells to LPS.

Dang X, Eliceiri BP, Baird A, Costantini TW.

FASEB J. 2015 Jun;29(6):2292-302. doi: 10.1096/fj.14-268037. Epub 2015 Feb 13.

12.

CHRFAM7A, a human-specific and partially duplicated α7-nicotinic acetylcholine receptor gene with the potential to specify a human-specific inflammatory response to injury.

Costantini TW, Dang X, Coimbra R, Eliceiri BP, Baird A.

J Leukoc Biol. 2015 Feb;97(2):247-57. doi: 10.1189/jlb.4RU0814-381R. Epub 2014 Dec 3. Review.

13.

Meta-analyses of 10 polymorphisms associated with the risk of schizophrenia.

Dai D, Wang Y, Yuan J, Zhou X, Jiang D, Li J, Zhang Y, Yin H, Duan S.

Biomed Rep. 2014 Sep;2(5):729-736. Epub 2014 Jun 30.

14.

Genetics of Psychosis in Alzheimer Disease.

DeMichele-Sweet MA, Sweet RA.

Curr Genet Med Rep. 2014 Mar;2(1):30-38.

15.

Systematic prioritization and integrative analysis of copy number variations in schizophrenia reveal key schizophrenia susceptibility genes.

Luo X, Huang L, Han L, Luo Z, Hu F, Tieu R, Gan L.

Schizophr Bull. 2014 Nov;40(6):1285-99. doi: 10.1093/schbul/sbu045. Epub 2014 Mar 24.

16.

Cotinine impacts sensory processing in DBA/2 mice through changes in the conditioning amplitude.

Wildeboer-Andrud KM, Zheng L, Choo KS, Stevens KE.

Pharmacol Biochem Behav. 2014 Feb;117:144-50. doi: 10.1016/j.pbb.2013.12.005. Epub 2013 Dec 26.

17.

Smoking behaviour and mental health disorders--mutual influences and implications for therapy.

Minichino A, Bersani FS, Calò WK, Spagnoli F, Francesconi M, Vicinanza R, Delle Chiaie R, Biondi M.

Int J Environ Res Public Health. 2013 Oct 10;10(10):4790-811. doi: 10.3390/ijerph10104790. Review.

18.

Association of the Nicotinic Receptor α7 Subunit Gene (CHRNA7) with Schizophrenia and Visual Backward Masking.

Bakanidze G, Roinishvili M, Chkonia E, Kitzrow W, Richter S, Neumann K, Herzog MH, Brand A, Puls I.

Front Psychiatry. 2013 Oct 22;4:133. doi: 10.3389/fpsyt.2013.00133. eCollection 2013.

19.

Association study of the 2-bp deletion polymorphism in exon 6 of the CHRFAM7A gene with idiopathic generalized epilepsy.

Rozycka A, Dorszewska J, Steinborn B, Lianeri M, Winczewska-Wiktor A, Sniezawska A, Wisniewska K, Jagodzinski PP.

DNA Cell Biol. 2013 Nov;32(11):640-7. doi: 10.1089/dna.2012.1880. Epub 2013 Sep 11.

20.

Nicotinic modulation of intrinsic brain networks in schizophrenia.

Smucny J, Tregellas J.

Biochem Pharmacol. 2013 Oct 15;86(8):1163-72. doi: 10.1016/j.bcp.2013.06.011. Epub 2013 Jun 21. Review.

Supplemental Content

Support Center